To help inform the current debate on assisted dying, we have updated the findings of our 2019 palliative report with the ...

Bhaven N. Sampat is an economist by training, a Professor at the Department of Health Policy and Management at Columbia University, and a Research Associate at the National Bureau of Economic Research ...

For the growing number of multi-indication medicines, challenges arise in assessing and paying for value across medicine indications with a uniform price (see our previous report and further ...

NICE's severity modifiers misalign with public preferences in England & Wales, prioritising health gains at lower disease ...

This blog by Martina Garau (OHE) and Dr. Tina Wang (CIRS) provides a framework to navigate key aims, challenges and opportunities offered by recent initiatives and reflects on future prospects.

Ting (Tina) Wang is Associate Director, HTA Programme and Strategic Partnerships at the Centre for Innovation in Regulatory Science (CIRS). Tina leads CIRS’ work on HTA strategy and research as part ...

Stuart Carroll is a senior health economist and epidemiologist with over 18 years of experience, specialising in infectious diseases and vaccines, market access, health technology appraisal, public ...

As Vice Provost (Strategic Research Partnerships) at SMU, Dr Cheong develops multi-disciplinary, strategic research partnerships with government and industry, to advance the international standing of ...

Lou Garrison, PhD, is Professor in the Pharmaceutical Outcomes Research and Policy Program in the School of Pharmacy, and Adjunct Professor in the Departments of Global Health and Health Services at ...

https://www.york.ac.uk/che/staff/research/martin-chalkley/ ...

Matthias is a Senior Economist at OHE and a Visiting Researcher at the Centre for Health Economics & Policy Innovation at Imperial College Business School. His expertise and research interests include ...